StockData
TTIPFOTCFiscal year ends February 28

Thiogenesis Therapeutics, Corp.

$0.37+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Thiogenesis Therapeutics, Corp. revenue by segment

No segment breakdown reported

Thiogenesis Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.